Wednesday, March 25, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Analysis

Unisys Faces Critical Earnings Test as Divisions Emerge

Dieter Jaworski by Dieter Jaworski
November 5, 2025
in Analysis, Earnings, Tech & Software
0
Unisys Stock
0
SHARES
23
VIEWS
Share on FacebookShare on Twitter

Today represents a pivotal moment for Unisys Corporation (UIS) as the technology services firm prepares to release its third-quarter 2025 financial results after the New York Stock Exchange closes. The market finds itself deeply divided about what to expect from this crucial earnings announcement.

Extreme Divergence in Profit Projections

While revenue expectations show relative consensus at approximately $494 million—only slightly below the previous year’s performance—the profit forecasts reveal startling disagreement among analysts. Some market researchers anticipate earnings of $0.01 per share, which would represent growth exceeding 100%. In stark contrast, other analysts project a substantial loss of $2.93 per share. This extraordinary discrepancy transforms today’s earnings release into a definitive directional event for the equity.

Building on Previous Quarter’s Momentum

The technology company enters this earnings period with positive momentum from its surprisingly strong second-quarter performance. During that period, Unisys significantly surpassed market expectations across key metrics. The company reported revenue of $483.3 million against projections of $444.65 million, while posting a loss per share of $0.28—markedly better than the anticipated $0.575 loss. This outperformance triggered an immediate 1.72% share price appreciation, raising questions about whether history might repeat itself with today’s results.

Should investors sell immediately? Or is it worth buying Unisys?

Strategic Government Contract Win

Adding to the positive backdrop, Unisys secured a significant four-year cybersecurity services agreement with the European Commission in October. The company leads the EUCybersafe consortium, providing services to 71 European Union institutions. This prestigious contract underscores the firm’s expanding presence in the public sector domain and represents a substantial vote of confidence in its cybersecurity capabilities.

Mixed Signals from Market Observers

Investment firms display varying degrees of optimism regarding Unisys’s prospects. Needham maintains a “Buy” recommendation with a $6.00 price target, while Jefferies advises a “Hold” position with a $4.00 target. The most bullish assessment comes from Maxim Group, which upgraded the stock to “Buy” with a $9.00 price objective. The average price target among analysts stands at $6.38, suggesting substantial upside potential from the current trading level of $3.47 per share.

However, recent trading patterns indicate growing investor apprehension. The stock has declined during six of the last ten trading sessions, resulting in a 5.71% loss over this period. Today’s earnings release will determine whether Unisys shares can reverse this downward trajectory or continue their recent slide.

Ad

Unisys Stock: Buy or Sell?! New Unisys Analysis from March 25 delivers the answer:

The latest Unisys figures speak for themselves: Urgent action needed for Unisys investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from March 25.

Unisys: Buy or sell? Read more here...

Tags: Unisys
Dieter Jaworski

Dieter Jaworski

About Dieter Jaworski From a numbers-obsessed child to creating his first investment newsletter. Even as a child, Dieter Jaworski's mother couldn't believe how fascinated he was with numbers. This early passion for mathematics and data analysis laid the foundation for a successful career in financial markets and investment analysis.
Areas of Expertise:
  • Quantitative Analysis
  • Financial Newsletter Publishing
  • Data-Driven Investment Strategies
  • Market Pattern Recognition
Dieter's unique approach combines his natural affinity for numbers with decades of market experience, providing investors with data-driven insights and practical investment strategies.

Related Posts

Gossamer Bio Stock
Analysis

Gossamer Bio’s Pivotal FDA Meeting Looms in June 2026

March 25, 2026
SOXX ETF Stock
Commodities

Semiconductor Sector Faces Supply Chain Strain Amid Helium Shortage Concerns

March 25, 2026
Fair Isaac Stock
Analysis

Regulatory Scrutiny and Price Wars Threaten Fair Isaac’s Dominance

March 25, 2026
Next Post
Cabot Stock

Cabot Shares Plunge as Weak Outlook Overshadows Solid Quarterly Performance

iShares MSCI Israel ETF Stock

Israeli Equity ETF Defies Geopolitical Headwinds with Impressive Gains

Thryv Holdings Stock

Thryv Holdings Shares Plunge Amid Analyst Downgrades and Growth Concerns

Recommended

Lockheed Martin Stock

Defense Giant Lockheed Martin Secures Billions in New Military Contracts

6 months ago
OKE stock news

Amalgamated Bank Increases Stake in CF Industries as Market Opinions Vary

3 years ago
IBM Stock

IBM’s AI Windfall Fails to Impress Stock Market

7 months ago
Blackstonecured Lending Fund Stock

Blackstone BDC Insider Purchase Defies Analyst Downgrades

4 months ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Bloom Energy Broadcom Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Newmont Mining NIO Novo Nordisk Nvidia Ocugen Oracle Palantir PayPal Plug Power QuantumScape Realty Income Robinhood Rocket Lab USA Salesforce Strategy Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

Figma Embraces Third-Party AI to Power Its Design Ecosystem

BioNano Genomics Stock: A Tale of Operational Gains and Revenue Headwinds

Humacyte Shares Hit Record Low Amid Capital Raise and Strategic Shifts

Evolent Health Bets on AI Leadership Amid Share Price Decline

MongoDB Strengthens Leadership Amid AI-Driven Growth Phase

Talphera Shares Slide as Funding Concerns Overshadow Clinical Progress

Trending

Gossamer Bio Stock
Analysis

Gossamer Bio’s Pivotal FDA Meeting Looms in June 2026

by Kennethcix
March 25, 2026
0

The future of Gossamer Bio hinges on a critical regulatory discussion scheduled for June 2026. The biopharmaceutical...

SOXX ETF Stock

Semiconductor Sector Faces Supply Chain Strain Amid Helium Shortage Concerns

March 25, 2026
Fair Isaac Stock

Regulatory Scrutiny and Price Wars Threaten Fair Isaac’s Dominance

March 25, 2026
Figma Stock

Figma Embraces Third-Party AI to Power Its Design Ecosystem

March 25, 2026
BioNano Genomics Stock

BioNano Genomics Stock: A Tale of Operational Gains and Revenue Headwinds

March 25, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Gossamer Bio’s Pivotal FDA Meeting Looms in June 2026
  • Semiconductor Sector Faces Supply Chain Strain Amid Helium Shortage Concerns
  • Regulatory Scrutiny and Price Wars Threaten Fair Isaac’s Dominance

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com